首页 | 本学科首页   官方微博 | 高级检索  
检索        

增强剂量CHOP方案治疗非霍奇金淋巴瘤51例
引用本文:黄强,孙酬经,汪涟明,钱美华,蓝建平,杨天新,王文松.增强剂量CHOP方案治疗非霍奇金淋巴瘤51例[J].肿瘤学杂志,1998(4).
作者姓名:黄强  孙酬经  汪涟明  钱美华  蓝建平  杨天新  王文松
作者单位:浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014,浙江省人民医院!杭州,310014
摘    要:〔目的〕探讨增强剂量CHOP方案治疗非霍奇金淋巴瘤的临床完全缓解率和3年生存率及骨髓抑制等情况。(方法)对51例非霍奇金淋巴瘤患者进行增强剂量CHOP方案治疗及良好的支持治疗并长期、定期治疗及随访。(结果)全组完全缓解率为784%;3年生存率为779%。(结论)增强剂量CHOP方案与传统CHOP方案相比在完全缓解率和3年生存率上有明显提高,而其骨髓抑制等毒副反应未见明显增加。

关 键 词:非霍奇金氏淋巴瘤  毒副反应  药物疗法  环磷酰胺  长春新碱

Treatment of Non-Hodgkin's Lymphoma with Reinforced CHOP Regimen (51 Cases Report)
Huang Qiang, Sun Choujin, Wang Lianhang,et al..Treatment of Non-Hodgkin's Lymphoma with Reinforced CHOP Regimen (51 Cases Report)[J].Journal of Oncology,1998(4).
Authors:Huang Qiang  Sun Choujin  Wang Lianhang  
Institution:Huang Qiang, Sun Choujin, Wang Lianhang, et al.
Abstract:Purpose] To study the effect of reinforced CHOP regimen in treating Non-Hodgkin's Lymphoma(NHL) in termsof clinical complete remssion(CR) rate, 3-year survival rate, and bone marrow inhibition. (Method] We used rein forced CHOPregimen to treat 51 NHL patients, along with supporting therapy, followed by regular, long-term treatment and follow-up. Re-sult]The CR rate was 78. 4%, the 3-year survival rate was 77. 9%. Conclusion] Reinforced CHOP reg imen has s igni ficant im-provement over traditional CHOP regimen in treating NHL in terms of CR rate and 3-year survival rate, and little increase in side-effect including bone marrow inhibition.
Keywords:Non-Hodgkin's lymphoma Adverse effect Drug therapy Cyclophosphandde Vincristine
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号